Nano-Hydroxyapatite-Derived Drug and Gene Co-Delivery System for Anti-Angiogenesis Therapy of Breast Cancer.

CONCLUSIONS p53/CD/NHAP might be a candidate carrier for efficient anti-angiogenesis therapy of breast cancer.
PMID: 28968380 [PubMed - in process]

Source: Medical Science Monitor - October 3, 2017 Category: Research Tags: Med Sci Monit Source Type: research